ストックスクリーナーアプリを入手
0.37
3.06%
0.011
アフターアワーズ：
.37
前日終値:
$0.359
開ける：
$0.3598
24時間の取引高:
1.35M
Relative Volume:
0.64
時価総額：
$31.04M
収益：
$1.22M
当期純損益:
$-14.15M
株価収益率:
-1.4231
EPS:
-0.26
ネットキャッシュフロー:
$-6.55M
1週間 パフォーマンス:
-1.25%
1か月 パフォーマンス:
+22.31%
6か月 パフォーマンス:
+7.75%
1年 パフォーマンス:
-19.57%
1日の値動き範囲:
$0.3551
$0.3739
1週間の範囲:
$0.32
$0.3739
52週間の値動き範囲:
$0.2525
$0.49
IGC Pharma Inc Stock (IGC) Company Profile
IGC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IGC
IGC Pharma Inc
|
0.37 | 31.43M | 1.22M | -14.15M | -6.55M | -0.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.53 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.52 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
566.14 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.93 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
IGC Pharma Inc (IGC) 最新ニュース
What analysts say about IGC Pharma Inc. stockBreakthrough wealth creation - jammulinksnews.com
Why IGC Pharma Inc. stock attracts strong analyst attentionDaily Breakout Picks - Newser
IGC Pharma Inc. Stock Analysis and ForecastExplosive earnings growth - Autocar Professional
What drives IGC Pharma Inc. stock priceGame-changing capital returns - Autocar Professional
IGC Pharma's Principal Scientist Dr. Jagadeesh Rao Receives Best Researcher Award at 11th Annual World Neuroscience Awards - ACCESS Newswire
Top Alzheimer's Researcher Beats 360 Global Scientists for Prestigious Neuroscience Award at IGC Pharma - Stock Titan
Can IGC Pharma Inc. stock recover from recent declineFast Growing Stocks - beatles.ru
Is IGC Pharma Inc. a good long term investmentFree Consultation - jammulinksnews.com
IGC Stock Offering: No Proceeds for the Company | IGC Stock News - GuruFocus
What makes IGC Pharma Inc. stock price move sharplyHigh Return Intraday Picks - Newser
JCR Pharma shares touch upper daily limit on Alzheimer's pact - AInvest
How IGC Pharma Inc. stock performs during market volatilityMarket Beating Strategy - Newser
AI in Healthcare: The Disruptive Force Redefining Medicine and Investment - AInvest
Cannabinoid Agonist Clinical Trial Pipeline Appears Robust - GlobeNewswire
Igc Pharma shares fall 6.39% in after-hours following strategic partnership announcement and launch of MINT-AD AI platform. - AInvest
IGC Pharma Introduces MINT-AD: Proprietary AI Platform to Predic - GuruFocus
IGC Pharma Introduces MINT-AD: Proprietary AI Platform to Predict Alzheimer's Risk and Accelerate Early Detection - ACCESS Newswire
New AI Breakthrough Could Detect Alzheimer's Years Before Symptoms: 400M People Could Benefit - Stock Titan
Healthcare Stocks Move in Pre-Market Session: Gainers and Losers - AInvest
The IGC Stock Puzzle: Unraveling IGC Pharma Inc’s Fluctuating Performance - investchronicle.com
IGC Pharma Stock Soars 57.92% on Partnership, Sustainability - AInvest
Massive 69.4% Surge for IGC Pharma in After-Hours Trading: Here's Why - Benzinga
IGC Pharma, Inc. (IGC) Reports Q4 Loss, Beats Revenue Estimates - MSN
Progress Software, Exicure, Quantum Corp. Earnings, Venus Concept, IGC Pharma Stocks To Watch Monday - AInvest
IGC Pharma Reports Transformative Year in Alzheimer’s Innovation - TipRanks
IGC Pharma: Fiscal Year 2025 Financial and Operational HighlightsA Year of Transformative Progress in Alzheimer's Innovation | IGC Stock News - GuruFocus
IGC Pharma to Host Fiscal Year-End 2025 Shareholder Update Call on Monday June 30, 2025 - ACCESS Newswire
IGC Pharma Full Year 2025 Results: Key Financial Updates Coming June 30What to Watch - Stock Titan
IGC Pharma Expands CALMA Trial to Oklahoma, Partnering with Dr. David McCoy at Tekton Research in Yukon - ACCESS Newswire
IGC Pharma's Phase 2 Alzheimer's Agitation Drug Trial Now Recruiting in Oklahoma: New Site Details - Stock Titan
IGC Pharma Highlights Alzheimer’s Research Progress - TipRanks
BARDA’s $375M to Shionogi for COVID-19 tops early list of 2025 grants - BioWorld MedTech
Plus Therapeutics (PSTV) Reports Q1 Loss, Misses Revenue Estimates - sharewise
IGC Pharma Launches Clinical Trial Site in Puerto Rico | IGC Sto - GuruFocus
IGC Pharma Inc (IGC) 財務データ
収益
当期純利益
現金流量
EPS
0.87%
0.17%
大文字化:
|
ボリューム (24 時間):